David W. Kimberlin

NIH Rank #1767
  • Program Award PI
  • Top 10% by Linked Awards

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1938230Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Pediatrics

NIH Funding · FY2026

Linked Award Amount
$2.3M
Full award amounts, FY2026
Award Records
1
Records listing this PI
Award-Linked Rank
#1,767
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing David W. Kimberlin as a PI. Multi-PI records show the full award amount for context.

  • 1U01AI195199-01U01
    Congenital Syphilis Treatment Trial (CONSISTENT): Phase IV, Open-label, Randomized Controlled Trial of Amoxicillin vs Benzathine Penicillin in Neonates with Possible Congenital Syphilis
    $2.3M
    award amount

Award organization

Organizations that administered FY2026 awards listing David W. Kimberlin as a PI.

FY2026 award administered by University of Alabama at Birmingham (AL).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    ScienceDex Coverage Begins
    Earliest loaded PI award records: FY2024
  2. 2024
    $500K Cumulative Linked Award Amount
  3. 2024
    $1M Cumulative Linked Award Amount
  4. 2024
    $2M Cumulative Linked Award Amount
  5. 2024
    $5M Cumulative Linked Award Amount
  6. 2024
    Reached Top 50% by Award-Linked Rank
    Ranked #619
  7. 2024
    Reached Top 25% by Award-Linked Rank
    Ranked #619
  8. 2024
    Reached Top 10% by Award-Linked Rank
    Ranked #619
  9. 2024
    Reached Top 5% by Award-Linked Rank
    Ranked #619